Rigosertib Active Not Recruiting Phase 3 Trials for Myelodysplastic Syndromes / Chronic Myelomonocytic Leukemia / Smith-Magenis Syndrome / Refractory anaemia with an excess of blasts Treatment

IndicationsStatusPurposePhase
Active Not RecruitingTreatment3
clinicaltrials.gov IdentifierTitleDrugs
NCT01241500Randomized Study of ON 01910.Na in Refractory Myelodysplastic Syndrome Patients With Excess Blasts